Valuation : Cannabis Bioscience International Holdings, Inc.

Market Cap 23.68L 20.4L 19.32L 17.51L 32.84L 23Cr 33.01L 2.29Cr 88.22L 12Cr 88.92L 86.97L 36Cr P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 33.68L 29.02L 27.48L 24.9L 46.72L 32Cr 46.96L 3.26Cr 1.25Cr 16Cr 1.26Cr 1.24Cr 52Cr EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
15/07 Cannabis Bioscience International Holdings Receives Texas License for Consumable Hemp Products CI
17/04 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
20/02 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
23/25/23 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
06/25/06 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
23/25/23 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
22/25/22 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
22/25/22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
22/25/22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
06/25/06 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
27/24/27 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
27/24/27 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
25/24/25 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
1 day-50.00%
1 week-33.33%
1 month-50.00%
3 months-66.67%
6 months-77.78%
Current year-80.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.01
10 years 0
Extreme 1.0E-6
0.27
Manager TitleAgeSince
Chief Executive Officer 70 19/12/2019
Treasurer 61 06/05/2024
Corporate Secretary 66 19/12/2019
Director TitleAgeSince
Director/Board Member 70 19/12/2019
Director/Board Member 66 19/12/2019
Director/Board Member 61 06/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-33.33%-83.33%-81.48% 12.06L
+1.39%-4.21%-1.86%+9.75% 4.55TCr
+0.21%-2.98%+337.74%+520.30% 4.37TCr
+1.74%-2.24%+39.82%+20.85% 4.31TCr
+1.38%-3.28%+6.84%+73.19% 3.94TCr
-1.44%-5.26%+8.97%+39.76% 3.19TCr
+0.87%-2.60% - - 1.73TCr
+0.75%-0.64%+19.75%+108.58% 1.64TCr
+1.54%+0.27%+13.81%+30.24% 1.42TCr
+1.93%-3.55%+82.00%+36.66% 1.33TCr
Average -4.16%-6.21%+47.08%+84.21% 2.65TCr
Weighted average by Cap. +0.87%-3.50%+74.95%+124.93%

Financials

2024 2025
Net sales 2L 2L 2L 2L 3L 2.38Cr 3L 24.11L 9L 1.21Cr 9L 9L 3.82Cr 3L 3L 2L 2L 4L 2.89Cr 4L 29.36L 11.29L 1.47Cr 11.38L 11.13L 4.65Cr
Net income -7L -6L -5L -5L -9L -6.22Cr -9L -63.11L -24.27L -3.17Cr -24.46L -23.93L -10Cr -5L -5L -4L -4L -8L -5.24Cr -8L -53.18L -20.45L -2.67Cr -20.61L -20.16L -8.43Cr
Net Debt 9L 8L 8L 7L 13.03L 8.97Cr 13.1L 91.02L 35L 4.57Cr 35.28L 34.5L 14Cr 10L 9L 8L 7L 13.88L 9.56Cr 13.95L 96.94L 37.28L 4.86Cr 37.57L 36.75L 15Cr
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
11/26/11 $0.000100 -50.00% 50,000
09/26/09 $0.000200 0.00% 5,00,000
08/26/08 $0.000200 +33.33% 25,07,000
  1. Stock Market
  2. Stocks
  3. CBIH Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!